Hester Biosciences Complete Financial Statements
HESTERBIO • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Hester Biosciences (HESTERBIO).
Downloads include all available records across all periods.
For market performance, see the
HESTERBIO stock price today
.
Profitability Ratios
Net Profit Margin
16.87%
2025 data
EBITDA Margin
28.92%
2025 data
Operating Margin
17.00%
2025 data
Return on Assets
2.14%
2025 data
Return on Equity
4.28%
2025 data
Balance Sheet Ratios
Current Ratio
0.97
2025 data
Debt to Equity
2.00
2025 data
Equity Ratio
50.08%
2025 data
Asset Turnover
0.13
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-4.6%
Year-over-Year
Net Profit Growth
+75.0%
Year-over-Year
EBITDA Growth
+9.1%
Year-over-Year
Expense Growth
-9.2%
Year-over-Year
Assets Growth
-1.4%
Year-over-Year
Equity Growth
+7.9%
Year-over-Year
Liabilities Growth
-1.4%
Year-over-Year
Operating Cash Flow Growth
+35.4%
Year-over-Year
Investing Cash Flow Growth
+13.0%
Year-over-Year
Financing Cash Flow Growth
-100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 83 | 76 | 88 | 87 | 84 | 84 | 72 | 76 | 71 | 90 | 69 | 78 | 64 | 55 | 81 | 64 | 67 | 63 | 59 | 54 | 48 | 41 | 58 | 45 | 58 | 45 | 51 | 43 | 41 | 46 |
| Expenses | 59 | 63 | 61 | 65 | 63 | 65 | 58 | 57 | 56 | 74 | 57 | 60 | 46 | 43 | 56 | 45 | 48 | 43 | 41 | 38 | 36 | 28 | 36 | 33 | 35 | 27 | 30 | 28 | 25 | 26 |
| EBITDA | 24 | 14 | 26 | 22 | 21 | 20 | 14 | 19 | 15 | 17 | 12 | 18 | 18 | 12 | 25 | 19 | 19 | 19 | 18 | 16 | 12 | 13 | 22 | 12 | 23 | 18 | 21 | 16 | 16 | 21 |
| Operating Profit Margin % | 17.00% | 23.00% | 27.00% | 23.00% | 20.00% | 21.00% | 8.00% | 19.00% | 17.00% | 16.00% | 15.00% | 17.00% | 18.00% | 15.00% | 25.00% | 28.00% | 26.00% | 28.00% | 27.00% | 30.00% | 16.00% | 30.00% | 37.00% | 25.00% | 33.00% | 39.00% | 41.00% | 36.00% | 37.00% | 44.00% |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 3 | 4 | 3 | 5 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 2 | 3 |
| Interest | 2 | 6 | 2 | 6 | 7 | 5 | -4 | 8 | 1 | 3 | 2 | 3 | 2 | 2 | 4 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 1 | 3 | 2 | 3 | 2 | 1 | 1 |
| Profit Before Tax | 17 | 4 | 20 | 12 | 10 | 11 | 13 | 7 | 8 | 9 | 6 | 10 | 11 | 6 | 16 | 15 | 14 | 15 | 12 | 11 | 6 | 8 | 18 | 7 | 17 | 13 | 15 | 10 | 12 | 17 |
| Tax | 3 | 2 | 3 | 4 | 4 | 3 | 2 | 3 | 3 | 2 | 2 | 4 | 2 | 2 | 4 | 4 | 4 | 4 | 3 | 4 | 2 | 3 | 5 | 1 | 3 | 5 | 3 | 5 | 4 | 4 |
| Net Profit | 14 | 2 | 17 | 8 | 6 | 8 | 11 | 4 | 6 | 7 | 4 | 7 | 9 | 4 | 12 | 11 | 10 | 11 | 8 | 7 | 5 | 5 | 13 | 6 | 14 | 8 | 12 | 6 | 8 | 12 |
| Earnings Per Share (₹) | 16.85 | 1.82 | 20.33 | 9.86 | 7.52 | 8.80 | 13.41 | 4.75 | 6.72 | 7.89 | 4.73 | 7.77 | 10.59 | 4.19 | 14.29 | 13.08 | 11.87 | 12.95 | 9.79 | 7.86 | 5.60 | 5.94 | 15.13 | 7.30 | 15.87 | 9.51 | 14.05 | 6.93 | 9.75 | 14.62 |
Related Pages for Hester Biosciences
Additional stock information and data for HESTERBIO
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 653 | 662 | 670 | 562 | 411 | 387 | 300 | 244 | 213 | 186 | 161 |
| Current Assets | 195 | 215 | 228 | 195 | 162 | 159 | 143 | 98 | 80 | 74 | 60 |
| Fixed Assets | 233 | 240 | 259 | 237 | 133 | 142 | 145 | 110 | 103 | 65 | 60 |
| Capital Work in Progress | 183 | 171 | 149 | 82 | 109 | 74 | 7 | 32 | 21 | 37 | 33 |
| Investments | 34 | 30 | 25 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 203 | 221 | 237 | 222 | 169 | 170 | 148 | 102 | 89 | 85 | 68 |
| LIABILITIES | |||||||||||
| Total Liabilities | 653 | 662 | 670 | 562 | 411 | 387 | 300 | 244 | 213 | 186 | 161 |
| Current Liabilities | 202 | 254 | 233 | 198 | 114 | 97 | 70 | 44 | 48 | 41 | 38 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 327 | 303 | 289 | 267 | 236 | 207 | 181 | 145 | 127 | 106 | 88 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 306 | 283 | 271 | 252 | 220 | 193 | 169 | 132 | 113 | 93 | 76 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 65 | 48 | 24 | 9 | 58 | 37 | 47 | 38 | 35 | 19 | 20 |
| Investing Activities | -20 | -23 | -77 | -117 | -42 | -73 | -21 | -26 | -30 | -13 | -21 |
| Financing Activities | -52 | -26 | 42 | 112 | -18 | 19 | 3 | -11 | 2 | -7 | 7 |
| Net Cash Flow | -7 | 0 | -12 | 4 | -2 | -17 | 28 | 1 | 6 | -1 | 5 |